INSM brensocatib approved in Japan for bronchiectasis
INSM says brinsupri (brensocatib) has been approved by Japan’s Ministry of Health, Labour and Welfare for patients with non-cystic fibrosis bronchiectasis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Insmed's Brinsupri wins Japan approval for bronchiectasis
Insmed says Japan's Ministry of Health, Labour and Welfare approved BRINSUPRI (brensocatib) for patients with non-cystic fibrosis bronchiectasis.